Frazier Healthcare Partners Adds Highly Experienced Pharma Executive to Growth Buyout Team
Frazier Healthcare Partners, a private equity firm focused on healthcare, has announced that Willis Chandler has joined their Growth Buyout team as an Executive in Residence. Chandler will help develop and execute investment strategies in pharma and pharmacy services, focusing on sourcing, diligence, and leadership of a new platform investment.
Chandler brings extensive experience, having most recently served as President of Global Pharma Services at Cencora (NYSE: COR), where he led a multi-billion dollar business unit with 10,000 employees. His background includes leadership roles at CVS Health and co-founding Shields Specialty Pharmacy. Chandler's expertise in entrepreneurial leadership, commercial transformation, and acquisition integration is expected to be valuable in Frazier's efforts to invest in disruptive growth-oriented healthcare companies.
Frazier Healthcare Partners, una società di private equity focalizzata sulla sanità, ha annunciato che Willis Chandler è entrato a far parte del loro team di Growth Buyout come Executive in Residence. Chandler aiuterà a sviluppare ed eseguire strategie di investimento in farmaci e servizi farmaceutici, concentrandosi sulla ricerca, la due diligence e la leadership di un nuovo investimento di piattaforma.
Chandler porta con sé un'esperienza significativa, avendo recentemente ricoperto il ruolo di Presidente dei Global Pharma Services presso Cencora (NYSE: COR), dove ha guidato una divisione aziendale da miliardi di dollari con 10.000 dipendenti. Il suo percorso include ruoli dirigenziali presso CVS Health e la co-fondazione di Shields Specialty Pharmacy. Si prevede che l'expertise di Chandler nella leadership imprenditoriale, nella trasformazione commerciale e nell'integrazione delle acquisizioni sarà preziosa negli sforzi di Frazier per investire in aziende sanitarie orientate alla crescita e al cambiamento.
Frazier Healthcare Partners, una firma de capital privado enfocada en el cuidado de la salud, ha anunciado que Willis Chandler se ha unido a su equipo de Growth Buyout como Ejecutivo en Residencia. Chandler ayudará a desarrollar y ejecutar estrategias de inversión en fármacos y servicios farmacéuticos, centrándose en la búsqueda, la diligencia debida y el liderazgo de una nueva inversión en plataforma.
Chandler aporta una amplia experiencia, habiendo ocupado recientemente el cargo de Presidente de Global Pharma Services en Cencora (NYSE: COR), donde lideró una unidad de negocios multimillonaria con 10,000 empleados. Su trayectoria incluye roles de liderazgo en CVS Health y la co-fundación de Shields Specialty Pharmacy. Se espera que la experiencia de Chandler en liderazgo emprendedor, transformación comercial e integración de adquisiciones sea valiosa en los esfuerzos de Frazier por invertir en empresas de atención médica orientadas al crecimiento disruptivo.
Frazier Healthcare Partners는 의료에 초점을 맞춘 사모펀드 회사로, Willis Chandler가 Growth Buyout 팀의 Executive in Residence로 합류했다고 발표했습니다. Chandler는 제약 및 약국 서비스에서 투자 전략을 개발하고 실행하는 데 도움을 줄 예정이며 신규 플랫폼 투자의 소싱, 실사 및 리더십에 집중할 것입니다.
Chandler는 최근 Cencora (NYSE: COR)에서 글로벌 제약 서비스의 사장으로 재직하며 10,000명의 직원을 둔 수십억 달러 규모의 비즈니스 유닛을 이끌어 온 상당한 경험을 가지고 있습니다. 그의 경력에는 CVS Health의 리더십 역할과 Shields Specialty Pharmacy 공동 설립이 포함됩니다. Chandler의 기업가적 리더십, 상업적 변화 및 인수 통합에 대한 전문 지식은 Frazier가 혁신적인 성장 지향 의료 기업에 투자하려는 노력에 유용할 것으로 기대됩니다.
Frazier Healthcare Partners, une société de capital-investissement spécialisée dans le secteur de la santé, a annoncé que Willis Chandler a rejoint leur équipe de Growth Buyout en tant qu'Executive in Residence. Chandler aidera à développer et à exécuter des stratégies d'investissement dans le secteur pharmaceutique et les services pharmaceutiques, en se concentrant sur la recherche, la diligence raisonnable et la direction d'un nouvel investissement plateforme.
Chandler apporte une vaste expérience, ayant récemment occupé le poste de Président des Global Pharma Services chez Cencora (NYSE: COR), où il a dirigé une unité commerciale de plusieurs milliards de dollars comptant 10 000 employés. Son parcours inclut des rôles de leadership chez CVS Health et la co-fondation de Shields Specialty Pharmacy. L'expertise de Chandler en matière de leadership entrepreneurial, de transformation commerciale et d'intégration des acquisitions devrait être précieuse dans les efforts de Frazier pour investir dans des entreprises de santé novatrices axées sur la croissance.
Frazier Healthcare Partners, eine Private-Equity-Firma, die sich auf das Gesundheitswesen konzentriert, hat bekannt gegeben, dass Willis Chandler ihrem Growth Buyout-Team als Executive in Residence beigetreten ist. Chandler wird dabei helfen, Investitionsstrategien in Pharma und Apothekenangebote zu entwickeln und umzusetzen, wobei der Schwerpunkt auf der Beschaffung, Due Diligence und Führung einer neuen Plattforminvestition liegt.
Chandler bringt umfangreiche Erfahrung mit, nachdem er zuletzt als Präsident der Global Pharma Services bei Cencora (NYSE: COR) tätig war, wo er eine milliardenschwere Geschäftseinheit mit 10.000 Mitarbeitern leitete. Sein Werdegang umfasst Führungspositionen bei CVS Health und die Mitbegründerrolle der Shields Specialty Pharmacy. Chandlers Expertise in unternehmerischer Führung, kommerzieller Transformation und Integrationsakquisitionen wird als wertvoll für die Bemühungen von Frazier erachtet, in disruptive wachstumsorientierte Gesundheitsunternehmen zu investieren.
- Addition of experienced pharma executive Willis Chandler to the Growth Buyout team
- Focus on expanding investments in the growing pharma and pharmacy services sector
- Chandler's extensive leadership experience in multi-billion dollar business units
- Potential for identifying and investing in disruptive growth-oriented healthcare companies
- None.
“The secular growth in pharma and pharmacy services has been an area of focus for Frazier for several years, and we are thrilled to welcome an industry veteran like Willis to our team,” said Nathan Every, General Partner at Frazier. “We are confident that his extensive leadership experience will be of great value as we partner with him to invest in this space.”
“I have long admired the way Frazier’s Growth Buyout team approaches sourcing and growing promising healthcare companies, and I am thrilled to be joining this great team,” said Mr. Chandler. “I am excited to work alongside Frazier to identify and work with disruptive growth-oriented healthcare companies.”
Mr. Chandler was most recently the President of Global Pharma Services at Cencora (NYSE: COR; f.k.a. Amerisource Bergen), where he led the multi-billion dollar business unit with 10,000 employees. Prior to his role leading the global pharma services segment, Mr. Chandler was Cencora’s President of Health System, Specialty, Government, and Commercial Solutions where he led all distribution and services into health systems and specialist facilities. Prior to Cencora, Mr. Chandler was the VP of Health System Alliances at CVS Health, and before that, he was the co-founder of Shields Specialty Pharmacy, a national leader in specialty pharmacy services for hospitals and health systems. Across his roles, Mr. Chandler has a demonstrated history of entrepreneurial leadership, commercial transformation, and acquisition integration.
About Frazier Healthcare Partners:
Founded in 1991, Frazier Healthcare Partners is a private equity firm focused exclusively on the healthcare industry. Since its inception, Frazier has raised over
For more information about Frazier Healthcare Partners, visit www.frazierhealthcare.com/home.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240910351030/en/
Frazier Healthcare Partners
Carol Eckert, VP of Investor Relations
Phone: 206.621.7200
Email: carol.eckert@frazierhealthcare.com
Source: Frazier Healthcare Partners
FAQ
Who is Willis Chandler and what role has he taken at Frazier Healthcare Partners?
What was Willis Chandler's most recent position before joining Frazier Healthcare Partners?
How does Frazier Healthcare Partners plan to utilize Willis Chandler's experience?
What is the significance of Willis Chandler joining Frazier Healthcare Partners for the company's investment strategy?
